ImmunityBio (IBRX) shares outstanding

Shares outstanding · fiscal 2025
919.86M

ImmunityBio (IBRX) had 919.86M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 31.3% higher than the 700.44M of fiscal 2024. Figures as of 18 Nov 2026, 12:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
919.86M
Change on fiscal 2024
+31.3%
Growth, 5 years
+19.5% a year
Highest on record
919.86Mfiscal 2025
Lowest on record
366.32Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

ImmunityBio shares outstanding, in more detail

The market data feed counts 1.06B shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 19.5% a year. Across the 7 fiscal years on record (2019–2025), the highest was 919.86M in fiscal 2025 and the lowest 366.32M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

ImmunityBio shares outstanding, year by year

ImmunityBio (IBRX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025919.86M 31.3% up
2024700.44M 37.7% up
2023508.64M 27.2% up
2022399.90M 2.7% up
2021389.23M 3.2% up
2020377.07M 2.9% up
2019366.32M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of ImmunityBio and comparable companies
CompanyShares outstandingFiscal year
Alkermes ALKS168.74M2025
PACS Group PACS156.70M2025
Kiniksa Pharmaceuticals International KNSA78.98M2025
ImmunityBio IBRX919.86M2025
Cytokinetics CYTK120.10M2025
ABIVAX ABVX69.53M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IBRX

ImmunityBio, figure by figure

ImmunityBio (IBRX) overview: price, valuation and scorecardAll health care companies by market value

ImmunityBio shares outstanding: questions and answers

How many shares does ImmunityBio have?

ImmunityBio (IBRX) had 919.86M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 31.3% higher than the 700.44M of fiscal 2024. The market data feed counts 1.06B shares outstanding today.

What is the growth rate of ImmunityBio's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 19.5% a year.

What are the highest and lowest diluted share count figures on record for ImmunityBio?

Across the 7 fiscal years on record (2019–2025), the highest was 919.86M in fiscal 2025 and the lowest 366.32M in fiscal 2019.

How is ImmunityBio's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For ImmunityBio it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ImmunityBio (IBRX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/IBRX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.